Cleared Traditional

K151359 - ROSA Brain

K151359 is an FDA 510(k) clearance for ROSA Brain, manufactured by Medtech S.A. The device is a Class 2 Neurology device with product code HAW cleared through the Traditional 510(k) pathway after a 212-day FDA review.

K151359 · Medtech S.A · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2015
Decision
212d
Days
Class 2
Risk

K151359 is an FDA 510(k) clearance for the ROSA Brain. Classified as Neurological Stereotaxic Instrument (product code HAW), Class II - Special Controls.

Submitted by Medtech S.A (Montpellier, FR). The FDA issued a Cleared decision on December 18, 2015 after a review of 212 days - an extended review cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.4560 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.

View all Medtech S.A devices

FDA 510(k) Submission Details - K151359

510(k) Number K151359 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 20, 2015
Decision Date December 18, 2015
Days to Decision 212 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
64d slower than avg
Panel avg: 148d · This submission: 212d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

HAW Device Classification - Class 2, Special Controls

Product Code HAW Neurological Stereotaxic Instrument
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.4560
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - HAW Neurological Stereotaxic Instrument

All 333
Devices cleared under the same product code (HAW) and FDA review panel - the closest regulatory comparables to K151359.
BrightMatter Guide with Surface Trace Registration
K153281 · Synaptive Medical, Inc. · Mar 2016
ClearPoint System
K160434 · Mri Interventions, Inc. · Mar 2016
Leksell Stereotactic System, Injection/ Aspiration Needle Kit
K152558 · Elekta Instrument AB · Mar 2016
SYMBIS Surgical System
K143420 · Imris, Inc. · Oct 2015
ClearPoint System
K142505 · Mri Interventions, Inc. · Oct 2015
NavSuite3 Kit
K150301 · Stryker Leibinger GmbH & Co. KG - Navigation · Jul 2015